Figure 1
Cumulative incidence of grade II-IV aGVHD. Cumulative incidence of grade II-IV aGVHD in all patients (A) and in patients receiving below versus above the median dose of (B) total iNKT, (C) CD4+ iNKT, and (D) CD4− iNKT cells.
Cumulative incidence of grade II-IV aGVHD. Cumulative incidence of grade II-IV aGVHD in all patients (A) and in patients receiving below versus above the median dose of (B) total iNKT, (C) CD4+ iNKT, and (D) CD4− iNKT cells.
